Xiaorong Dong

The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Cancer

X. Yi, F. Tong, H. Zeng, 2022, Frontiers in Immunology.

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy

F. Tong, Rui-guang Zhang, Yu Huang, 2021, Frontiers in Oncology.

Correction to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

F. Tong, Rui-guang Zhang, Gang Wu, 2017, Journal of Hematology & Oncology.

MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Gang Wu, F. Tong, Rui-guang Zhang, 2017, Journal of Hematology & Oncology.

BRD4‐IRF1 axis regulates chemoradiotherapy‐induced PD‐L1 expression and immune evasion in non‐small cell lung cancer

Tao Zhang, Shuangbing Xu, Gang Wu, 2022, Clinical and translational medicine.